Faes Farma, S.A. (BME:FAE)
Spain · Delayed Price · Currency is EUR 4.750
+0.140 (3.04%)
Oct 6, 2026, 5:37 PM CET
Faes Farma Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,479 | 1,606 | 1,083 | 992 | 1,074 | 1,019 | |
Market Cap Growth | 8.76% | 48.28% | 9.15% | -7.61% | 5.44% | 3.90% |
Enterprise Value | 1,793 | 1,643 | 1,062 | 962 | 1,008 | 962 |
Last Close Price | 4.75 | 5.05 | 3.29 | 2.88 | 3.06 | 3.01 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.71 | 20.17 | 9.73 | 10.80 | 12.00 | 12.36 |
Forward PE | 14.67 | 18.27 | 11.65 | 11.04 | 12.10 | 12.89 |
PS Ratio | 2.08 | 2.56 | 2.12 | 2.10 | 2.33 | 2.38 |
PB Ratio | 1.91 | 2.15 | 1.49 | 1.50 | 1.78 | 1.90 |
P/TBV Ratio | 5.65 | 5.22 | 1.97 | 2.02 | 2.41 | 2.73 |
P/FCF Ratio | 23.66 | 25.75 | 13.27 | 190.61 | 33.75 | 36.18 |
P/OCF Ratio | 18.41 | 20.46 | 9.38 | 9.83 | 10.03 | 12.79 |
PEG Ratio | 0.84 | 0.96 | 1.33 | 1.33 | 1.98 | 1.43 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.52 | 2.62 | 2.08 | 2.03 | 2.18 | 2.25 |
EV/EBITDA Ratio | 13.66 | 14.65 | 8.52 | 8.12 | 8.55 | 8.65 |
EV/EBIT Ratio | 18.26 | 18.49 | 9.78 | 9.36 | 9.89 | 9.91 |
EV/FCF Ratio | 28.67 | 26.33 | 13.00 | 184.81 | 31.69 | 34.17 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.58 | 0.58 | 0.04 | 0.04 | 0.06 | 0.04 |
Debt / EBITDA Ratio | 3.42 | 3.72 | 0.21 | 0.24 | 0.31 | 0.19 |
Debt / FCF Ratio | 7.19 | 6.95 | 0.32 | 5.48 | 1.16 | 0.76 |
Net Debt / Equity Ratio | 0.40 | 0.41 | -0.06 | -0.03 | -0.08 | -0.10 |
Net Debt / EBITDA Ratio | 2.49 | 2.70 | -0.37 | -0.16 | -0.40 | -0.47 |
Net Debt / FCF Ratio | 5.00 | 4.86 | -0.56 | -3.70 | -1.48 | -1.85 |
Asset Turnover | 0.58 | 0.57 | 0.63 | 0.63 | 0.67 | 0.70 |
Inventory Turnover | 1.42 | 1.39 | 1.28 | 1.32 | 1.46 | 1.52 |
Quick Ratio | 1.66 | 1.61 | 1.84 | 1.84 | 2.09 | 2.34 |
Current Ratio | 2.63 | 2.61 | 3.23 | 3.33 | 3.32 | 3.70 |
Return on Equity (ROE) | 11.22% | 10.82% | 15.99% | 14.49% | 15.70% | 16.32% |
Return on Assets (ROA) | 5.03% | 5.06% | 8.33% | 8.55% | 9.28% | 9.90% |
Return on Invested Capital (ROIC) | 8.57% | 9.58% | 16.38% | 15.29% | 17.28% | 19.51% |
Return on Capital Employed (ROCE) | 7.90% | 7.70% | 14.50% | 14.90% | 16.10% | 17.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.69% | 4.96% | 10.28% | 9.26% | 8.33% | 8.09% |
FCF Yield | 4.23% | 3.88% | 7.54% | 0.53% | 2.96% | 2.76% |
Dividend Yield | 2.69% | 2.54% | 5.44% | 5.38% | 5.07% | 6.85% |
Payout Ratio | 66.19% | 69.97% | 43.32% | 15.89% | 20.28% | 5.99% |
Buyback Yield / Dilution | -0.43% | -0.20% | -0.56% | -1.57% | -0.36% | -4.38% |
Total Shareholder Return | 2.26% | 2.34% | 4.89% | 3.81% | 4.71% | 2.47% |